Enterome’s new OncoMimics™ immunotherapy, EO2463, demonstrates early efficacy and favorable safety in Phase 1/2 trial for indolent non-Hodgkin lymphoma

10 months ago

EO2463 uniquely targets four distinct B cell markers to maximize tumor killing and prevent immune escape, generating fast, strong and…

Philips’ direct-to-angio stroke pathway: new analysis demonstrates substantial cost savings in addition to improved patient outcomes

10 months ago

Philips Neuro suite June 14, 2023 Economic analysis of cost of Vall d’Hebron University Hospital Stroke Unit shows direct-to-angio stroke…

CancerVAX Launches $10 Million Funding Round

10 months ago

Proceeds from the SEC qualified Reg A+ offering will allow the Company to continue work on its breakthrough cancer treatmentsLEHI,…

Statement re: Award of Invention of Innovation FAST Grant

10 months ago

DXS INTERNATIONAL PLC (AQSE: DXSP) Award of Invention of Innovation FAST Grant for Hypertension Management DXS International plc (AQSE: DXSP)…

RadNet Announces Pricing of Upsized Public Offering of Common Stock

10 months ago

LOS ANGELES, June 13, 2023 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site…

Texas-Based Practice Selects eClinicalWorks EHR for Behavioral Health Module

10 months ago

Life is a Journey transitions to eClinicalWorks for key features that provide patient-centered careWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the largest ambulatory cloud…

Masimo Board of Directors Highlights Value of Company’s Mission-Driven Innovation in Letter to Stockholders

10 months ago

Emphasizes Track Record of Innovation Powering Growth, Stockholder Value Creation Under Joe Kiani’s Leadership Illuminates Risk Quentin Koffey Poses to…

Cardio Diagnostics Publishes Research Highlighting the Reversibility of Epigenetic Signatures of Coronary Heart Disease

10 months ago

The study represents a significant breakthrough in understanding the potential for reversing and measuring epigenetic changes associated with coronary heart…

LivaNova Announces 150th Bipolar Depression Patient Randomized in RECOVER Clinical Study

10 months ago

LONDON--(BUSINESS WIRE)--#advancedcirculatorysupport--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the 150th bipolar depression patient has…